Pediatric surgery international · 2026
Long-term outcomes of tracheostomy in patients with congenital diaphragmatic hernia.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kawaguchi Yunosuke, Nagata Kouji, Umeda Satoshi, Sato Yoshiaki, Okuyama Hiroomi, Maruyama Hidehiko, Yokoi Akiko, Toyoshima Katsuaki, Miyake Yuichiro, Kim Kiyokazu, Koike Yuhki, Yamoto Masaya, Sato Yasunori, Terui Keita
Аннотация
PURPOSE: Data on long-term follow-up after tracheostomy in patients with congenital diaphragmatic hernia (CDH) are limited. We assessed current tracheostomy status and clinical characteristics in relation to decannulation during long-term follow-up.
METHODS: In this multicenter retrospective study, we analyzed the Japanese CDH Study Group database records from 2006 to 2023. Clinical characteristics of patients undergoing tracheostomy during hospitalization were reviewed. Using long-term follow-up data, decannulation status was assessed and decannulation rates were estimated via Kaplan-Meier analysis.
RESULTS: We included 1284 patients, 38 of whom underwent tracheostomy during hospitalization. Compared with the non-tracheostomy group, the tracheostomy group had higher rates of severe cardiac anomalies (21% vs. 9%), more chromosomal abnormalities (26% vs. 7%), greater gestational age (median 37w6d vs. 37w1d), and lower birth weight (median 2468 g vs. 2704 g). Survival among the tracheostomy cohort was 74.4%, 63.7%, and 53.1% at 6, 9, and 12 years, respectively. The cumulative decannulation rate at age 6 years was 36%. Pulmonary vasodilator use at discharge was significantly more common in non-decannulated patients.
CONCLUSION: Among all CDH infants, 3.0% required tracheostomy. The cumulative decannulation rate at 6 years was 36%. Pulmonary vasodilator use at discharge was more common in non-decannulated patients.
METHODS: In this multicenter retrospective study, we analyzed the Japanese CDH Study Group database records from 2006 to 2023. Clinical characteristics of patients undergoing tracheostomy during hospitalization were reviewed. Using long-term follow-up data, decannulation status was assessed and decannulation rates were estimated via Kaplan-Meier analysis.
RESULTS: We included 1284 patients, 38 of whom underwent tracheostomy during hospitalization. Compared with the non-tracheostomy group, the tracheostomy group had higher rates of severe cardiac anomalies (21% vs. 9%), more chromosomal abnormalities (26% vs. 7%), greater gestational age (median 37w6d vs. 37w1d), and lower birth weight (median 2468 g vs. 2704 g). Survival among the tracheostomy cohort was 74.4%, 63.7%, and 53.1% at 6, 9, and 12 years, respectively. The cumulative decannulation rate at age 6 years was 36%. Pulmonary vasodilator use at discharge was significantly more common in non-decannulated patients.
CONCLUSION: Among all CDH infants, 3.0% required tracheostomy. The cumulative decannulation rate at 6 years was 36%. Pulmonary vasodilator use at discharge was more common in non-decannulated patients.